03 September 2023
10.00 am - 1.00 pm
Dr James Hawkins, Facilitator
MDMA-assisted therapy is already prescribable in Australia and should soon be in the UK as well. It’s predicted that its use for treatment-resistant trauma will be licensed in the States next year. Licensing of psilocybin-assisted therapy is likely to follow not long afterwards. Clients will ask us about these developments. What would it be helpful for us to know about the potential of these medicines?
James Hawkins is founder of the Psychedelic Health Professionals Network, an educational organisation that provides legal retreats in the Netherlands, publishes a free weekly newsletter about emerging research, and runs a one-year course on psychedelics for interested counsellors and other health professionals – see psychedelicnetwork.org.uk.
Booking Fee: £10 – Exclusive to PF Counsellors
Location
PF Counselling Service